PAHC
PHIBRO ANIMAL HEALTH CORP
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$34.56
+0.33%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $0.78
- Revenue estimate
- $381.7M
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- $0.85
- EPS estimate
- $0.72
- Revenue actual
- $396.7M
- Revenue estimate
- $386.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +18.5%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 27, 2026 | $0.72 | $0.85 | Beat 18.72% | $396.7M |
| May 7, 2026 | $0.72 | $0.76 | Beat 5.56% | $383.5M |
| Feb 4, 2026 | $0.69 | $0.87 | Beat 26.09% | $373.9M |
| Nov 5, 2025 | $0.59 | $0.73 | Beat 23.73% | $363.9M |
| Aug 27, 2025 | $0.52 | $0.57 | Beat 9.62% | $378.7M |
| May 7, 2025 | $0.52 | $0.63 | Beat 21.15% | $347.8M |
| Feb 5, 2025 | $0.40 | $0.54 | Beat 35.00% | $309.3M |
| Nov 7, 2024 | $0.25 | $0.35 | Beat 40.00% | $260.4M |
| Aug 28, 2024 | $0.34 | $0.41 | Beat 20.59% | $273.2M |
| Feb 7, 2024 | $0.27 | $0.33 | Beat 22.22% | $249.9M |
| Aug 30, 2023 | $0.40 | $0.38 | Miss -4.76% | $255.0M |
| May 3, 2023 | $0.34 | $0.29 | Miss -14.71% | $245.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026